End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,990 IDR | +4.91% | +1.36% | +4.91% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Analyst opinion has improved significantly over the past four months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- With an expected P/E ratio at 36.62 and 32.66 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- Based on current prices, the company has particularly high valuation levels.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+4.91% | 2.46B | - | ||
-18.46% | 16.57B | B+ | ||
+4.50% | 12.38B | B | ||
+4.31% | 11.73B | B+ | ||
+24.72% | 8.4B | B | ||
-2.64% | 7.63B | A- | ||
+20.04% | 7.16B | D | ||
+4.17% | 6.63B | B- | ||
+46.90% | 4.58B | - | ||
-5.70% | 4.22B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- MIKA Stock
- Ratings PT Mitra Keluarga Karyasehat Tbk